Vascular Solutions Reports Second Quarter Results
July 22, 2014 16:05 ET
|
Vascular Solutions, Inc.
- Record quarterly revenues increase 12% to $30.7 million
- GAAP earnings per share increase 9% to $0.18
- Raising bottom-end of 2014 revenue guidance range to $123 million from $121 million,...
Vascular Solutions, Inc. Issues Recall of Langston(R) Dual Lumen Catheters
July 03, 2014 16:05 ET
|
Vascular Solutions, Inc.
MINNEAPOLIS, July 3, 2014 (GLOBE NEWSWIRE) -- On May 23, 2014, Vascular Solutions, Inc. (Nasdaq:VASC) initiated a voluntary nationwide recall of Langston dual lumen catheters used in catheterization...
Vascular Solutions, Inc. to Webcast Second Quarter Conference Call
July 01, 2014 16:05 ET
|
Vascular Solutions, Inc.
MINNEAPOLIS, July 1, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its second quarter conference call on Tuesday, July 22nd at...
Vascular Solutions Launches Gel-Bead(TM) Embolization Spheres
June 19, 2014 16:05 ET
|
Vascular Solutions, Inc.
- Precisely sized, bioresorbable gelatin beads intended for embolization of hypervascular tumors
- Designed for use by interventional radiologists who currently use microspheres, PVA particles,...
Vascular Solutions to Participate in Bank of America Merrill Lynch 2014 Health Care Conference
May 01, 2014 16:05 ET
|
Vascular Solutions, Inc.
MINNEAPOLIS, May 1, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to participate in the Bank of America Merrill Lynch 2014 Health Care...
Vascular Solutions Reports First Quarter Results
April 22, 2014 16:05 ET
|
Vascular Solutions, Inc.
Record revenues increase 15% to $29.9 million, reflecting growth in all three product categories
EPS increases 26% to $0.16, including above-budget legal expenses that reduced first quarter...
Vascular Solutions Enters Into Agreement With U.S. Army to Develop Freeze-Dried Plasma Product
April 22, 2014 16:03 ET
|
Vascular Solutions, Inc.
- U.S. Army will sponsor, conduct and fund all Food and Drug Administration (FDA) required pre-clinical and clinical studies of the freeze-dried plasma product developed by Vascular Solutions
-...
Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter Vacated by Federal Circuit
April 15, 2014 11:50 ET
|
Vascular Solutions, Inc.
MINNEAPOLIS, April 15, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) announced that a three judge panel of the U.S. Court of Appeals for the Federal Circuit today vacated the...
Vascular Solutions Surpasses 50,000 Successfully Reprocessed ClosureFAST(R) Catheters
April 09, 2014 16:05 ET
|
Vascular Solutions, Inc.
-- Reprocessing of popular vein treatment catheter results in significant cost savings and reduced medical waste for U.S. vein clinics
-- Excellent safety record established, with no serious...
Vascular Solutions, Inc. to Webcast First Quarter Conference Call
April 08, 2014 16:05 ET
|
Vascular Solutions, Inc.
MINNEAPOLIS, April 8, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its first quarter conference call on Tuesday, April 22nd at...